Literature DB >> 10516509

Specific expression of alanine-glyoxylate aminotransferase 2 in the epithelial cells of Henle's loop.

I S Lee, M Nishikimi, M Inoue, Y Muragaki, A Ooshima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10516509     DOI： 10.1159/000045507

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  5 in total

Review 1.  AGXT2: a promiscuous aminotransferase.

Authors:  Roman N Rodionov; Natalia Jarzebska; Norbert Weiss; Steven R Lentz
Journal:  Trends Pharmacol Sci       Date:  2014-10-13       Impact factor: 14.819

2.  Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.

Authors:  Roman N Rodionov; Daryl J Murry; Sarah F Vaulman; Jeff W Stevens; Steven R Lentz
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

Review 3.  Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?

Authors:  Ben Caplin; James Leiper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-29       Impact factor: 8.311

Review 4.  The Second Life of Methylarginines as Cardiovascular Targets.

Authors:  Natalia Jarzebska; Arduino A Mangoni; Jens Martens-Lobenhoffer; Stefanie M Bode-Böger; Roman N Rodionov
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

5.  Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.

Authors:  Dmitry V Burdin; Alexey A Kolobov; Chad Brocker; Alexey A Soshnev; Nikolay Samusik; Anton V Demyanov; Silke Brilloff; Natalia Jarzebska; Jens Martens-Lobenhoffer; Maren Mieth; Renke Maas; Stefan R Bornstein; Stefanie M Bode-Böger; Frank Gonzalez; Norbert Weiss; Roman N Rodionov
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.